Carolinas Wealth Consulting LLC Ionis Pharmaceuticals Inc Transaction History

Carolinas Wealth Consulting LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$33.58 - $41.2 $873 - $1,071	-26 Reduced 13.9%	161 $5,000
Q4 2021 Feb 14, 2022	SELL	$25.61 - $35.1 $76,830 - $105,300	-3,000 Reduced 94.13%	187 $6,000
Q2 2021 Aug 17, 2021	SELL	$34.54 - $47.25 $172,700 - $236,250	-5,000 Reduced 61.07%	3,187 $127,000
Q1 2021 May 17, 2021	SELL	$42.51 - $63.78 $4,888 - $7,334	-115 Reduced 1.39%	8,187 $368,000
Q4 2020 Feb 16, 2021	BUY	$45.3 - $60.27 $234,971 - $312,620	5,187 Added 166.52%	8,302 $469,000
Q3 2020 Nov 12, 2020	BUY	$47.45 - $62.95 $5,456 - $7,239	115 Added 3.83%	3,115 $148,000
Q2 2020 Aug 13, 2020	BUY	$46.85 - $61.05 $140,550 - $183,150	3,000 New	3,000 $177,000

402

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Carolinas Wealth Consulting LLC, based on Form 13F filings with the SEC.

Stay updated on Carolinas Wealth Consulting LLC with notifications on news.